Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels

Nature Medicine

Volumn 4, Issue 12, 1998, Pages 1434-1437

  Karvonen, Matti K ^a   Pesonen, Ullamari ^a   Koulu, Markku ^a   Niskanen, Leo ^b   Laakso, Markku ^b   Rissanen, Aila ^c   Dekker, Jacqueline M ^d   'T Hart, Leen M ^e   Valve, Raisa ^b   Uusitupa, Matti I J ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LEUCINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUROPEPTIDE Y; PROLINE; SIGNAL PEPTIDE;

ADULT; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

ADULT; AGED; ALLELES; AMINO ACID SUBSTITUTION; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LEUCINE; MALE; MIDDLE AGED; NEUROPEPTIDE Y; OBESITY; POLYMORPHISM, GENETIC; PROLINE; PROTEIN SORTING SIGNALS;

EID: 20244365772     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/4027     Document Type: Article

References (16)

1. Gray, T.S. & Morley, J.E. Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Nature 38, 389-401 (1986).
2. Lundberg, J.M. et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol. Scand. 116, 477-480 (1982).
3. Clark, J.T., Kalra, P.S. & Kalra, S.P. Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology 117, 2435-2442 (1985).
4. Levine, A.S. & Morley, J.E. Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides 5, 1025-1029 (1985).
5. Stanley, B.G. & Leibowitz, S.F. Neuropeptide Y injected in the paraventricular hpothalamus: a powerful stimulant of feeding behavior. Proc. Natl. Acad. Sci. USA 82, 3940-3943 (1985).
6. Billington, C.J., Briggs, J.E., Grace, M. & Levine, A.S. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am. J. Physiol. 260, R321-R327 (1991).
7. Billington, C.J., Briggs, J.E., Harker, S., Grace, M. & Levine, A.S. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am. J. Physiol. 266, R1765-R1770 (1994).
8. Uusitupa, M.I. et al. Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women. Am. J. Clin. Nutr. 64, 131-136 (1996).
9. Ehnholm, C., Lukka, M., Kuusi, T., Nikkilä, E. & Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J. Lipid. Res. 27, 227-235 (1986).
10. Chan L. Apolipoprotein B, the major protein component of triglyceride rich and low density lipoprotein. J. Biol. Chem. 267, 25621-25624 (1992).
11. Nystrom, F., Nilsson, P., Olsson, A.G., Karlberg, B.E. & Ohman, K.P. A population study of plasma neuropeptide Y: correlations with components of the metabolic syndrome. Blood Press. 5, 349-353 (1996).
12. Lundberg, J.M., Franco-Cereceda, A., Hemsen, A., Lacroix, J.S. & Pernow, J. Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission. Fundam. Clin. Pharmacol. 4, 373-391 (1990).
13. 3-adrenergic receptor gene affects basal metabolic rate in obese Finns. Diabetes 46, 77-80 (1997).
14. Uusitupa, M., Siitonen, O., Aro, A. & Pyörälä K. Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 28, 22-27 (1985).
15. Uusitupa, M., Niskanen, L., Siitonen, O., Voutilainen, E. & Pyörälä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36, 1175-1184 (1993).
16. Mooy, J.M. et al. Prevalence and determinants of glucose intolerance in a Dutch Caucasian population. The Hoorn Study. Diabetes Care 18, 12701273 (1995).